title: Pericardial effusion in patients with schizophrenia: are they on clozapine?
abstract: Clozapine is used in the treatment of resistant schizophrenia. It is used as a reserve drug mainly because of its adverse effect profile affecting gastrointestinal, haematological and cardiorespiratory systems. Cardiac side effects are uncommon but could be potentially life threatening, hence early recognition and active monitoring are essential to prevent serious cardiac side effects. A case of pericarditis with pericardial effusion is described in a patient who was recently started on clozapine which disappeared within 1 week after discontinuation of clozapine.
authors.affiliation: Cardiovascular Research Group, University Hospital Aintree, Liverpool, UK. dr_prashanthraj@yahoo.com
authors.forename: P
authors.initials: P
authors.lastname: Raju
authors.forename: G K
authors.initials: GK
authors.lastname: Rao
authors.forename: G
authors.initials: G
authors.lastname: Davis
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D010490:Pericardial Effusion / Q000139:chemically induced* / Q000000981:diagnostic imaging; D010493:Pericarditis / Q000139:chemically induced / Q000000981:diagnostic imaging; D012559:Schizophrenia / Q000188:drug therapy*; D014463:Ultrasonography
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine